MEGAN ZIOLA: Open Payments
NPI 1780342139 · MINNEAPOLIS, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$520 in 28 payments from 19 companies in 2025. Trend: 2023 $187 · 2024 $220 · 2025 $520
Food & beverage: $520
| Company | Payments | Amount |
|---|---|---|
| Cycle Pharmaceuticals Inc | 3 | $78 |
| BioCryst US Sales Co., LLC | 3 | $45 |
| CSL Behring | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Axsome Therapeutics, Inc. | 2 | $32 |
| Baxter Healthcare | 1 | $32 |
| ABBVIE INC. | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Verona Pharma, Inc. | 1 | $19 |
Products named: Sajazir, ORLADEYO, TEZSPIRE, DUPIXENT, Symbravo, Hillrom - Vest System Model 105 Home Care, Haegarda, Rhapsido.
Industry payments across MN — which companies pay providers there.
